Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Novo Nordisk (NVO) and Eli Lilly (LLY). But which of these two stocks is more attractive to valu
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
Are you reluctant to invest in stocks right now? That's understandable.
The Investment Committee debate the latest Calls of the Day.
"Billionaire" and "successful hedge fund manager" are titles that carry significant weight on Wall Street. These and others apply to Ken Griffin, CEO and founder of Citadel.
AbbVie Inc. entered the obesity market by in-licensing GUBamy, a long-acting amylin analog, a modest but important first step to challenge Eli Lilly and Novo Nordisk. AbbVie's will pay $350 million up
The Investment Committee give you their top stocks to watch for the second half.
U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, with both citing increased threats after a UnitedHealth insurance executive was murdere
Though Eli Lilly stock looks quite expensive, we suggest investors hold on to it as it still has robust growth prospects.

Is Eli Lilly Stock a Buy?

04:10am, Tuesday, 11'th Mar 2025
Like many pharma stocks, Eli Lilly (LLY -4.58%) offers investors a bit of safety -- and it's an element you can count on during any economic environment. This is because patients need their medicines

Why Eli Lilly Stock Flopped Today

06:54pm, Monday, 10'th Mar 2025
Eli Lilly (LLY -4.58%) stock has had plenty of good trading sessions over the past year or so, but Monday's sure wasn't among them. The storied pharmaceutical company's shares lost nearly 5% of their
Eli Lilly and Company (NYSE:LLY ) Leerink 2025 Global Healthcare Conference March 10, 2025 9:20 AM ET Company Participants Lucas Montarce - CFO Mike Czapar - Head of IR Conference Call Participants Da
The Danish company said the average weight loss was 15.7% for the new drug, CagriSema. The expectation had been about 25%.
Eli Lilly and INCY announce positive efficacy data from the late-stage alopecia study of baricitinib in adolescent patients.

2 Stocks That Could Split Very Soon

09:59am, Monday, 10'th Mar 2025
Stock splits tend to create a lot of buzz in the market, especially when some of the most prominent companies announce a split.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE